RecruitingNCT05386615
Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
Sponsor
InSightec
Enrollment
200 participants
Start Date
Feb 16, 2016
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this Registry Study is to capture clinical pregnancy outcomes and fibroid treatment background data for any subject post-Exablate treatment for their symptomatic fibroids.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years
Plain Language Summary
Simplified for easier understanding
This registry study is tracking pregnancy outcomes in women who previously had their uterine fibroids treated with a non-surgical procedure called Exablate focused ultrasound, which uses sound wave energy directed at fibroids to shrink them without any incisions. The goal is to understand the long-term effects on fertility and pregnancy after this treatment.
**You may be eligible if...**
- You have had your uterine fibroids treated with the Exablate focused ultrasound system
- You have consented to having your health outcomes tracked in this pregnancy outcomes registry
**You may NOT be eligible if...**
- You have not consented to join the registry
- You received Exablate treatment for a reason other than symptomatic fibroids
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEBody System - Functional
MR-Guided Focused Ultrasound
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05386615
Related Trials
The Impact of a Novel GnRH Antagonist With Add-back Therapy for Treatment of Uterine Fibroids and Endometriosis on Hemostasis Parameters
NCT071731271 location
Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)
NCT061536674 locations
Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE
NCT067050751 location